MKI67 and invasive breast carcinoma: Intra-laboratory reproducibility of testing the same cases for; estrogen receptors (ER), progesterone receptors (PR), human epidermal growth factor receptor-2 (HER2) and Ki-67 proliferating antigen by the ten laboratories on cases of invasive breast cancer on two separate occasions.